Nutex Health Inc. (NUTX)
Healthcare · NCM
Price as at 1 Oct 2026, 11:44 UTC. Quotes are delayed.
Fundamentals
Valuation and ratings
Nutex Health Inc. trades at $211.66, which is 71% below the $361.68 our fair value estimate puts on the business. On that measure alone it screens as undervalued, though a valuation model is an argument rather than a measurement, and the market is frequently right about why something is cheap.
Our moat model scores it 60 out of 100, which is a moat, but not a deep one. A moat is a structural reason competitors cannot take the profits away, and it matters more to a long holding period than any single quarter's numbers do.
It changes hands at 12.0 times earnings. Be careful reading that in isolation: for a cyclical business a low P/E arrives at the top of the cycle, when profits are peaking and about to fall, which is exactly when the shares look cheapest and are not.
NUTX dividend history
No individual payments are on record for this listing, so the current facts above are all we can honestly show.
NUTX earnings and analyst estimates
Recommendation mix, 5 published ratings
Estimates are the published analyst consensus and move often. An earnings date is scheduled, not certain, and a share tends to reprice most violently on the day itself.
About Nutex Health Inc.
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatient pharmacies. The PHM segment provides management, administrative, and other support services to its affiliated hospitals and physician groups by establishing and operating provider networks, such as independent physician associations (IPAs); and a cloud-based technology platform for IPAs. The Real Estate segment owns and leases land and hospital buildings. Nutex Health Inc. was founded in 2011 and is headquartered in Houston, Texas.
Company profile, industry and headcount are as reported by our data provider and can lag a company's own filings by a reporting period. The annual report is the authority.
NUTX passes 2 of our 30 screens today
Each screen prints the exact criteria it used, and the circumstances in which it is wrong.
Super investor ownership
4 of the funds we track reported a position in their latest SEC 13F filing. Largest first:
- D. E. Shaw, D. E. Shaw & Co., Inc.$16.65M · 0.0% of book
- Israel Englander, MILLENNIUM MANAGEMENT LLC$8.90M · 0.0% of book
- Ken Griffin, CITADEL ADVISORS LLC$3.13M · 0.0% of book
- Joel Greenblatt, Gotham Asset Management, LLC$556.8K · 0.0% of book
A word of warning on reading these figures: a 13F reports the market value of a holding, so a fund that traded nothing at all still appears to have sold when the price fell. We found 102 companies where the standard reading gives the opposite answer. Only the share count is honest.
NUTX peers
The largest companies in the same industry (Medical Care Facilities), then in the same sector.
- FSNUY Fresenius SE & Co. KGaA
- THC Tenet Healthcare Corporation
- FMS Fresenius Medical Care AG
- ENSG The Ensign Group, Inc.
- UHS Universal Health Services, Inc.
- RHC.AX Ramsay Health Care Limited
- CHE Chemed Corporation
- CON Concentra Group Holdings Parent, Inc.
Every healthcare company we cover is on the Healthcare hub.
Common questions
Is Nutex Health Inc. (NUTX) undervalued?
Against our fair value estimate of $361.68, NUTX at $211.66 is 71% below fair value. That is one model's answer, not a recommendation. It is built from normalized earning power with growth capped deliberately low, which understates companies whose value is mostly future growth.
Which funds own NUTX?
4 of the institutions we track reported a position in NUTX in their most recent SEC 13F filing. A 13F is filed up to 45 days after quarter end, so it tells you what a fund held then, not what it holds now.
What is NUTX's P/E ratio?
NUTX trades at 12.0 times earnings. A low P/E is not automatically cheap: on a cyclical company it is usually a warning that earnings are at a peak.
Where does SteadyShares get its NUTX data?
Fundamentals for NUTX come from company filings and exchange data, as listed on NCM; institutional ownership comes from SEC 13F filings. The share price shown was last refreshed on 1 Oct 2026, 11:44 UTC and is delayed. Our data quality score for this company is 96/100, which is the share of the inputs behind our scores that were actually available rather than assumed. Metrics we do not hold are left out of the page rather than estimated.
The full research page for NUTX, with financial statements, ownership detail, peer comparison and alerts, is free inside the app.
Data from company filings, exchange quotes and SEC EDGAR 13F disclosures. Quotes are delayed. Metrics we do not have are left out rather than estimated. Educational information, not financial advice.